Puma Biotechnology (PBYI) Capital Expenditures Growth (5y) (2016 - 2025)
Puma Biotechnology (PBYI) Capital Expenditures Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Puma Biotechnology | 407.78 Mn | 369.49 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.95% |
| Sep 30, 2025 | 54.55% |
| Jun 30, 2025 | -119.54% |
| Mar 31, 2025 | 36.23% |
| Dec 31, 2023 | 15.65% |
| Sep 30, 2023 | -15.43% |
| Dec 31, 2020 | -17.17% |
| Sep 30, 2020 | -57.18% |
| Jun 30, 2020 | 67.01% |
| Mar 31, 2020 | -50.44% |
| Dec 31, 2018 | -32.02% |
| Sep 30, 2018 | -6.68% |
| Jun 30, 2018 | 25.76% |
| Mar 31, 2018 | -26.22% |
| Dec 31, 2017 | -29.78% |
| Sep 30, 2017 | -5.19% |
| Jun 30, 2017 | -30.40% |
| Mar 31, 2017 | -7.89% |
| Jun 30, 2016 | 287.89% |